康复新液联合泮托拉唑钠肠溶胶囊治疗消化性溃疡的效果  

Effect of Kangfuxin Liquid combined with Pantoprazole Sodium Enteric Capsules in the treatment of peptic ulcer

作　　者：厉琴 李静如 马智慧 张莉 高小花 汪银莹 LI Qin;LI Jing-ru;MA Zhi-hui;ZHANG Li;GAO Xiao-hua;WANG Yin-ying(Department of Gastroenterology,Huai′an Medical Area,General Hospital of Chinese People′s Liberation Army Eastern Theater Command,Jiangsu Province,Huai′an223001,China)

机构地区：[1]解放军东部战区总医院淮安医疗区消化内科,江苏淮安223001

出　　处：《中国当代医药》2021年第12期84-88,共5页China Modern Medicine

摘　　要：目的探讨康复新液联合泮托拉唑钠肠溶胶囊治疗消化性溃疡的效果。方法选取2015年12月~2017年3月就诊于解放军东部战区总医院淮安医疗区的88例消化性溃疡患者作为研究对象,按照治疗方案的不同将其分为观察组(42例)和对照组(46例)。对照组患者予泮托拉唑钠肠溶胶囊治疗,观察组患者采用康复新液联合泮托拉唑钠肠溶胶囊治疗。观察组中,胃溃疡20例,十二指肠球部溃疡22例;对照组中,胃溃疡22例,十二指肠球部溃疡24例。比较两组患者的各项临床症状(上腹痛、腹胀、嗳气及反酸)改善时间;比较两组患者治疗前后的临床症状评分;比较两组患者的整体治疗效果;比较两组十二指肠球部溃疡、胃溃疡患者的治疗效果;比较两组患者的不良反应发生情况;比较两组愈合患者随访第6个月及12个月的溃疡复发率。结果治疗8周后,观察组患者的上腹痛、腹胀、嗳气及反酸改善时间短于对照组,差异有统计学意义(P<0.05)。两组患者治疗后的上腹痛、腹胀、嗳气及反酸症状评分低于治疗前,且治疗后观察组患者的上腹痛、腹胀、嗳气及反酸症状评分低于对照组,差异均有统计学意义(P<0.05)。观察组患者的愈合率及整体治疗总有效率高于对照组,差异有统计学意义(P<0.05)。治疗后,观察组十二指肠球部溃疡患者、胃溃疡患者的痊愈率及总有效率高于对照组,差异有统计学意义(P<0.05)。两组患者治疗后的不良反应总发生率比较,差异无统计学意义(P>0.05)。随访第6个月及12个月,观察组患者的溃疡复发率低于对照组,差异有统计学意义(P<0.05)。结论康复新液联合泮托拉唑钠肠溶胶囊治疗消化性溃疡的效果显著,愈合时间短,复发率低,不良反应少,值得临床推广应用。Objective To investigate the effect of Kangfuxin Liquid combined with Pantoprazole Sodium Enteric Capsules in the treatment of peptic ulcer. Methods A total of 88 patients with peptic ulcer who were treated in Huai′an Medical Area, General Hospital of Chinese People′s Liberation Army Eastern Theater Command from December 2015 to March 2017 were selected as the research subjects, and they were divided into observation group (42 cases) and control group (46 cases) according to different treatment regimen. Control group was treated with Pantoprazole Sodium Enteric Capsules, and observation group was treated with Kangfuxin Liquid combined with Pantoprazole Sodium Enteric Capsules. In the observation group, there were 20 cases of gastric ulcer and 22 cases of duodenal bulb ulcer. In the control group, there were 22 cases of gastric ulcer and 24 cases of duodenal ulcer. The improvement time of various clinical symptoms (epigastric pain, abdominal distention, belching and acid reflux) was compared between the two groups. Clinical symptom scores of two groups were compared before and after treatment. The overall treatment effect of the two groups was compared. The treatment effect of duodenal bulb ulcer and gastric ulcer was compared between the two groups. The incidence of adverse reaction was compared between the two groups. The recurrence rate of ulcer in healed patients was compared between the two groups at 6 and 12 months of follow-up. Results After 8 weeks of treatment, the improvement time of epigastric pain, abdominal distention, belching and acid reflux in the observation group was shorter than that in the control group, with statistical significance (P<0.05). The scores of epigastric pain, abdominal distention, belching and acid reflux symptoms in the two groups after treatment were lower than those before treatment, and the scores of epigastric pain, abdominal distention, belching and acid reflux symptoms in the observation group were lower than those in the control group after treatment, with statistical

关 键 词：康复新液 泮托拉唑钠肠溶胶囊 消化性溃疡 效果 

分 类 号：R573.1[医药卫生—消化系统]